ACM
GILD icon

Argonaut Capital Management’s Gilead Sciences GILD Stock Holding History

Argonaut Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$835K Hold
8,500
– – 2.8% 16
2015
Q2 		$995K Buy
+8,500
New +$929K 2.88% 16

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Argonaut Capital Management's GILD Position: Q3 2015 in Review

Argonaut Capital Management held its Gilead Sciences (GILD) position steady in Q3 2015 at 16,900 shares worth $1.66M. The position accounts for 5.57% of the portfolio, ranked #3.

Argonaut Capital Management first reported a position in GILD in Q1 2014 and has held it in 7 quarters since. The position peaked at $1.98M in Q2 2015. 1,573 funds tracked by Wall St. Rank hold GILD as of Q3 2015.

  • Argonaut Capital Management held 16,900 shares of Gilead Sciences worth $1.66M as of Q3 2015.
  • Argonaut Capital Management left its Gilead Sciences share count unchanged in Q3 2015.
  • Gilead Sciences made up 5.57% of Argonaut Capital Management's portfolio in Q3 2015, its #3 holding.
  • Argonaut Capital Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 7 quarters since.
  • Argonaut Capital Management's Gilead Sciences position peaked at $1.98M in Q2 2015.
  • 1,573 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2015.

Based on Argonaut Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.